Compounds > arabinofuranosyluracil

arabinofuranosyluracil and Dysmyelopoietic Syndromes

arabinofuranosyluracil has been researched along with Dysmyelopoietic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arning, M; Burk, M; Fartash, K; Heyll, A; Schneider, W; Volmer, M1

Other Studies

1 other study(ies) available for arabinofuranosyluracil and Dysmyelopoietic Syndromes

ArticleYear
Pharmacokinetics of high-dose cytarabine and its deamination product--a reappraisal.
    Leukemia & lymphoma, 1997, Volume: 27, Issue:3-4

    Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Cytarabine; Deamination; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes

1997